Multicenter retrospective study of the prognosis and the effect of postoperative adjuvant therapy in Japanese oral squamous cell carcinoma patients with close margin.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
06 2023
Historique:
revised: 18 01 2023
received: 18 07 2022
accepted: 14 03 2023
medline: 12 5 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: ppublish

Résumé

The purpose of this retrospective study was to investigate the prognosis of patients with oral cavity cancer with positive margin (PM) or close margin (CM) divided into pN- and pN+ groups. The evaluated endpoints were local control and disease-specific survival (DSS) rates. Higher T classification, lymphovascular space invasion (LVSI), and older age were significant risk factors for DSS in the pN- groups. On the other hand, extranodal extension, multiple lymph node metastases, and LVSI were significant risk factors for DSS in the pN+ groups. Among the CM pN+ patients, no significant differences in the 3-year DSS were observed between the only surgery (51.9%) and adjuvant groups (53.2%). Higher T classification and LVSI are high-risk features more than PM or CM in the pN- groups for DSS. However, further prospective studies are needed to demonstrate the usefulness of adjuvant treatment in patients with PM or CM.

Sections du résumé

BACKGROUND
The purpose of this retrospective study was to investigate the prognosis of patients with oral cavity cancer with positive margin (PM) or close margin (CM) divided into pN- and pN+ groups.
METHODS
The evaluated endpoints were local control and disease-specific survival (DSS) rates.
RESULTS
Higher T classification, lymphovascular space invasion (LVSI), and older age were significant risk factors for DSS in the pN- groups. On the other hand, extranodal extension, multiple lymph node metastases, and LVSI were significant risk factors for DSS in the pN+ groups. Among the CM pN+ patients, no significant differences in the 3-year DSS were observed between the only surgery (51.9%) and adjuvant groups (53.2%).
CONCLUSIONS
Higher T classification and LVSI are high-risk features more than PM or CM in the pN- groups for DSS. However, further prospective studies are needed to demonstrate the usefulness of adjuvant treatment in patients with PM or CM.

Identifiants

pubmed: 36951203
doi: 10.1002/hed.27355
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1418-1429

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Kalavrezos N, Bhandari R. Current trends and future perspectives in the surgicalmanagement of oral cancer. Oral Oncol. 2010;46:429-432.
Kernohan MD, Clark JR, Gao K, Ebrahimi A, Milross CG. Predicting the prognosisof oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg. 2010;136:1235-1239.
Huang TY, Hsu LP, Wen YH, et al. Predictors of locore-gional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol. 2010;46:49-55.
Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy forlocally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.
Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparativeanalysis of concurrent postoperative radiation plus chemotherapy trials of theEORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843-850.
Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2003;32(1):30-34.
Bessell A, Glenny AM, Furness S, et al. Interventions for the treatment of oral and oropharyngeal cancers: Surgical treatment. Cochrane Database Syst Rev. 2011;9:CD006205.
Dixit S, Vyas RK, Toparani RB, Baboo HA, Patel DD. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: A comparative study. Ann Surg Oncol. 1998;5(6):502-510.
Hinni ML, Ferlito A, Brandwein-Gensler MS, et al. Surgical margins in head and neck cancer: A contemporary review. Head Neck. 2013;35(9):1362-1370.
Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: Current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck. 2005;27(11):952-958.
Nason RW, Binahmed A, Pathak KA, Abdoh AA, Sándor GKB. What is the adequate margin of surgical resection in oral cancer? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(5):625-629.
Wong LS, McMahon J, Devine J, et al. Influence of close resection margins on local recurrence and disease-specific survival in oral and oropharyngeal carcinoma. Br J Oral Maxillofac Surg. 2012;50(2):102-108.
Ch'ng S, Corbett-Burns S, Stanton N, et al. Close margin alone does not warrant postoperative adjuvant radiotherapy in oral squamous cell carcinoma. Cancer. 2013;119(13):2427-2437.
Weijers M, Snow GB, Bezemer DP, van der Wal JE, van der Waal I. The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence; an analysis of 68 patients. Int J Oral Maxillofac Surg. 2004;33(2):146-149.
Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990;160(4):410-414.
Liao CT, Chang JT, Wang HM, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915-922.
Hicks WL Jr, North JH Jr, Loree TR, et al. Surgery as a single modality therapy for squamous cell carcinoma of the oral tongue. Am J Otolaryngol. 1998;19:24-28.
Binahmed A, Nason RW, Abdoh AA. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol. 2007;43(8):780-784.
Kademani D, Bell RB, Bagheri S, et al. Prognostic factors in intraoral squamous cell carcinoma: The influence of histologic grade. J Oral Maxillofac Surg. 2005;63(11):1599-1605.
McMahon JD, Devine JC, Hetherington J, et al. Involved surgical margins in oral and oropharyngeal carcinoma-An anatomical problem? Br J Oral Maxillofac Surg. 2011;49(3):172-175.
McMahon J, O'Brien CJ, Pathak I, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41(4):224-231.
Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167-178.
Solomon J, Hinther A, Matthews TW, et al. The impact of close surgical margins on recurrence in oral squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2021;50(1):9.
Kurita H, Nakanishi Y, Nishizawa R, et al. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol. 2010;46(11):814-817.
Yang TL, Wang CP, Ko JY, et al. Association of tumor satellite distance with prognosis and contralateral neck recurrence of tongue squamous cell carcinoma. Head Neck. 2008;30(5):631-638.
Byers RM, Bland KI, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg. 1978;136(4):525-528.
Slootweg PJ, Hordijk GJ, Schade Y, van Es RJJ, Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol. 2002;38(5):500-503.
Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys. 1987;13(6):833-837.
Hamman J, Howe CL, Borgstrom M, Baker A, Wang SJ, Bearelly S. Impact of close margins in head and neck mucosal squamous cell carcinoma: A systematic review. Laryngoscope. 2022;132(2):307-321.
Fives C, Feeley L, O'Leary G, Sheahan P. Importance of lymphovascular invasion and invasive front on survival in floor of mouth cancer. Head Neck. 2016;38(Suppl 1):E1528-E1534.
Jones HB, Sykes A, Bayman N, et al. The impact of lymphovascular invasion on survival in oral carcinoma. Oral Oncol. 2009;45(1):10-15.
Tai SK, Li WY, Chu PY, et al. Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck. 2012;34(7):994-1001.
Chen TC, Wang CP, Ko JY, et al. The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients. Ann Surg Oncol. 2013;20(7):2388-2395.
Huang S, Zhu Y, Cai H, Zhang Y, Hou J. Impact of lymphovascular invasion in oral squamous cell carcinoma: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(3):319-328.e1.
Hasegawa T, Tanakura M, Takeda D, et al. Risk factors associated with distant metastasis in patients with oral squamous cell carcinoma. Otolaryngol Head Neck Surg. 2015;152(6):1053-1060.
Hasegawa T, Shibuya Y, Takeda D, et al. Prognosis of oral squamous cell carcinoma patients with level IV/V metastasis: An observational study. J Craniomaxillofac Surg. 2017;45(1):145-149.
Yanamoto S, Denda Y, Ota Y, et al. Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence. Int J Oral Maxillofac Surg. 2020;49(7):848-853.
Okura M, Yanamoto S, Umeda M, et al. Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma. Cancer Med. 2016;5(12):3378-3385.
Shibuya Y, Ohtsuki Y, Hirai C, et al. Oral squamous cell carcinoma with microscopic extracapsular spread in the cervical lymph nodes. Int J Oral Maxillofac Surg. 2014;43(4):387-392.
Hamilton SN, Arshad O, Kwok J, et al. Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy. Support Care Cancer. 2019;27(7):2609-2616.
Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-A report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32(3):289-295.
Brown JS, Blackburn TK, Woolgar JA, et al. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol. 2007;43(8):764-773.
Moergel M, Meurer P, Ingel K, Wendt TG, al-Nawas B. Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1): A meta-analysis. Strahlenther Onkol. 2011;187(6):337-343.
Ampil FL, Caldito G, Ghali GE, Nathan CO. Postoperative radiotherapy for insecure or positive surgical margins in head and neck cancer. J Oral Maxillofac Surg. 2003;61(4):425-429.
Barry CP, Wong D, Clark JR, et al. Postoperative radiotherapy for patients with oral squamous cell carcinoma with intermediate risk of recurrence: A case match study. Head Neck. 2017;39(7):1399-1404.
Liu T, Chua B, Batstone M. Postoperative radiotherapy for oral squamous cell carcinoma with histologic risk factors: Are we over-treating? J Oral Maxillofac Surg. 2018;76(7):1565-1570.
Jang JY, Choi N, Ko YH, et al. Differential impact of close surgical margin on local recurrence according to primary tumor size in oral squamous cell carcinoma. Ann Surg Oncol. 2017;24(6):1698-1706.

Auteurs

Takumi Hasegawa (T)

Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Yasumasa Kakei (Y)

Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Nobuhiro Yamakawa (N)

Department of Oral and Maxillofacial Surgery, School of Medicine, Nara Medical University, Kashihara, Japan.

Tadaaki Kirita (T)

Department of Oral and Maxillofacial Surgery, School of Medicine, Nara Medical University, Kashihara, Japan.

Masaya Okura (M)

Department of Oral and Maxillofacial Surgery, Saiseikai Matsusaka General Hospital, Mie, Japan.
The First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, Osaka, Japan.

Tomofumi Naruse (T)

Unit of Translational Medicine, Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Mitsunobu Otsuru (M)

Unit of Translational Medicine, Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Shin-Ichi Yamada (SI)

Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.

Hiroshi Kurita (H)

Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

Eiji Hirai (E)

Department of Oral and Maxillofacial Surgery, Oita Red Cross Hospital, Oita, Japan.

Shin Rin (S)

Department of Oral Surgical Oncology, Hokkaido Cancer Center, Sapporo, Japan.

Michihiro Ueda (M)

Department of Oral Surgical Oncology, Hokkaido Cancer Center, Sapporo, Japan.

Masahiro Umeda (M)

Unit of Translational Medicine, Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Masaya Akashi (M)

Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH